World Class Speakers


The World Biosimilar Congress agenda will feature 300+ speakers across multiple streams and co-located events.

Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.


2018 Speakers confirmed to date


Jenny Alltoft, Head of Global Biosimilars, Pfizer

Jenny Alltoft at World Biosimilar Congress

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Stephen Beers, Associate Professor, University Of Southampton

Phil Bland-Ward, Chief Scientific Officer, Crescendo Biologics Ltd

Phil Bland-Ward at World Biosimilar Congress

Dr Ezio Bonvini, CSO, Macrogenics

Frank Brennan, Head of Non-Clinical Toxicology and PK/PD (Immunology), UCB Pharma

Dr Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche

Sebastian Bunk, Research Director, Immunology, Immatics Biotechnologies GmbH

Patrick Burke, Associate Director, Seattle Genetics Inc

Martina Canestraro, Senior Research Scientist, Immunocore Ltd

Paul Carter, Senior Director and Staff Scientist, Antibody Engineering, Genentech

Kieran Casey, Business Development Manager, Services, Bioreclamation IVT

Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury at World Biosimilar Congress

Daniela Cipolletta, Lab Head, Exploratory Immuno Oncology, Novartis

Daniela Cipolletta at World Biosimilar Congress

Nathalie Corvaïa, Managing Director, Institut De Recherche Pierre Fabre

Nathalie Corvaïa at World Biosimilar Congress

Prentice Curry, Vice President Quality and Operations, Kite Pharma Inc

Prentice Curry at World Biosimilar Congress

Dr William Dall'Acqua, VP, R&D, MedImmune

Igor D'Angelo, Senior Scientist and Functional Lead, Amgen Inc

Dr John Delaney, Executive Director, Amgen Biologics Discovery, Amgen

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at World Biosimilar Congress

Prof Stefan Dübel, Director, Department of Biotechnology, Braunschweig University of Technology

Dr Peter Ellmark, Principal Scientist, Immuno-oncology, Alligator Bioscience Ab

Stephan Ewert, Senior Investigator, Novartis Pharma AG

Hanspeter Gerber, CSO and President, Maverick Therapeutics

Hanspeter Gerber at World Biosimilar Congress

Eric Halioua, President and Chief Executive Officer, PDC*line pharma SA

Dr Steffen Hartmann, Global Head Integrated Biologics Profiling, Novartis

Michael Hust, Group Leader, Technical University of Braunschweig

Kevin Johnson, Partner, Medicxi

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology

Dr Sidath Katugampola, Biomarker Development Specialist, Cancer Research U.K. Cambridge Institute

Robert Kelley, Principal Scientist, Genentech

Robert Kelley at World Biosimilar Congress

Shirin Khambata Ford, Executive Director of Oncology Biomarker and Diagnostics Leader, Merck Oncology

Shirin Khambata Ford at World Biosimilar Congress

David Klatzmann, Professor, Pierre et Marie Curie University and Medical School

David Klatzmann at World Biosimilar Congress

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Heinz Läubli, Attending Physician, Medical Oncology, University Hospital Basel

Andreas Hougaard Laustsen, Postdoctoral Fellow, Technical University of Denmark

Zhaoyang (Megan) Li, Director, Translational Medicine & Clinical Pharmacology, Sanofi

Krzysztof Masternak, Head of Biology, NovImmune Sa

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Derek Michael Mason, PhD Candidate, ETH Zurich

Enkelejda Miho, Pioneer, ETH Zurich

Vera Molkenthin, Chief Scientist, Abcheck s.r.o.

Dr M. Anthony Moody, Associate Professor of Paediatrics, Assistant Professor of Immunology, Duke University Medical Center

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Dr Ahuva Nissim, Reader, William Harvey Research Institute

Benjamí Oller-Salvia, EMBO postdoctoral fellow, M.R.C. Laboratory of Molecular Biology

Dr Shane Olwill, Vice President of Development, Pieris Pharmaceuticals

Nora Pencheva, Lead Scientist, Humax-AXL-ADC Program, Genmab

Nicole Piche-Nicholas, Senior Scientist, Pfizer

Nicole Piche-Nicholas at World Biosimilar Congress

Dr Alexey Rak, Head of Bio Structure and Biophysics, Sanofi

Dr Alexey Rak at World Biosimilar Congress

Ulrich Rant, Chief Executive Officer, Dynamic Biosensors

Ulrich Rant at World Biosimilar Congress

Dr Fabian Richter, Post-Doctoral Fellow, University of Stuttgart

Theo Rispens, Group Leader, Sanquin

Yun Sanders, Senior scientist, Crescendo Biologics

Yun Sanders at World Biosimilar Congress

Dr Jose Saro, T.M.L. Pharma Research and Early Development, Oncology, Roche

Darko Skegro, Senior Investigator, Biotherapeutic Technologies, Novartis Institutes for Biomedical Research

Dr Oliver Spadiut, Group Leader of Integrated Bioprocess Development, Vienna University of Technology

Pawel Stocki, Senior Principal Scientist, Ossianix, Inc.

Dr Michael Streit, Sr Director Clinical Research Lead, Janssen

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Immutep Ltd

Dr Mihriban Tuna, Vice President, Drug Discovery, F-Star

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Dr Carl Webster, Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune Cambridge

Dr Martin Welschof, Chief Executive Officer, Opsona Therapeutics Ltd

Dr Jens Würthner, Head of Clinical Development – EU, ADC Therapeutics

Wei Xu, Principal Scientist, Analytical Method Development, Merck Research Laboratories

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc

Ildiko Ziegler at World Biosimilar Congress



World Biosimilar Congress

Adam Levysohn , Sr Director Market Access Biosimilar, Biogen
Alain Beck
, Senior Director Analytical Chemistry, CIPF and Associate Editor, mAbs
Alain Vertes
, Managing Director, NxR Biotechnologies
Ber Oomen
, Executive Secretary, European Specialist Nurses Organisations
Cecil Nick
, Vice President, Biotechnology, PAREXEL
Divya Chadha Manek
, Head of Commercial Business Development & Marketing, NIHR Clinical Research Network (NIHR CRN)
Gianluca Trifirò
, Department of Biomedical Sciences, Dentistry and Morphological and Functional Images, University of Messina – Italy
Ian Henshaw
, Global Head of Business Operations and Alliance Management, Biogen
Ingrid Schwarzenberger
, Head Global Regulatory Affairs, Sandoz Biopharmaceuticals
Jatinder Harchowal
, Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Pharmacy Dept, The Royal Marsden NHS Foundation Trust
Jonathan Underhill
, Medicines Clinical Adviser, Medicines and Technologies Programme (MTP), NICE
Karsten Roth
, Director Clinical Operations and Pharmacovigilance, Cinfa Biotech GmbH
Philip Ball
, Market Access Manager, NAPP Pharmaceuticals
Ruediger Jankowsky
, Managing Director, Cinfa Biotech GmbH
Shantreddy Soogareddy
, Associate Director External R&D, Dr. Reddy's Laboratories SA.
Steinar Madsen
, Medical Director, Norwegian Medicines Agency
Tim Shea
, Director, Sterne, Kessler, Goldstein & Fox
Uwe Gudat
, Head of Safety, Biosimilars, Merck


European Antibody Congress

Alain Beck , Senior Director, NBEs Analytical Chemistry, Pierre Fabre ; Associate Editor, mAbs 
Alexey Rak
, Head of Bio Structure and Biophysics, S anofi R&D
Andreas Hougaard Laustsen
, Postdoctoral Fellow, Tropical Pharmacology Lab, Technical University of Denmark 
Carl Webster, Principal Scientist
, Antibody Discovery and Protein Engineering, MedImmune
Christoph Merten
, Group Leader Microfluidics, European Molecular Biology Laboratory
Darko Skegro
, Senior Investigator, Biotherapeutic and Analytical Technologies, NIBR
Ezio Bonvini
, MD - CSO, Macrogenics
Fabian Richter
, Post-Doc, University of Stuttgart
Frank Brennan
, Senior Director, UCB Celltech
Frank Walsh
, CEO, Ossianix
Helena Domingues
, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office
Igor D’Angelo
, Team Lead, Antibody Engineering, Amgen British Colombia 
Ivan Mascanfroni
, Senior Scientist, Immunology Biologics, AbbVie
Janice Reichert
, Executive Director, The Antibody Society ; Editor-in-Chief, mABs
Jens Würthner
, Assistant Vice President, Head of Clinical Development – EU, ADC Therapeutics
Jiri Kovarik
, Research Investigator, Novartis
John Delaney
, Executive Director of Research, Amgen
Krzysztof Masternak
, Head of Biology, NovImmune
Michael Streit
, Senior Director, Clinical Leader Research, Translational Medicine and Early Development, Oncology, Janssen
Nathalie Corvaia
, Director, CIPF, Pierre Fabre
Oliver Spadiut
, Assistant Professor, Integrated Bioprocess Development, TU Wien
Patrick Burke
, Associate Director of Chemistry, Seattle Genetics
Peter Ellmark
, Principal Scientist, Immuno-Oncology, Alligator Bioscience
Peter Senter
, VP, Distinguished Research Fellow, Seattle Genetics
Roy Baynes
, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Senior representative, AbCheck
Senior representative, Abzena
Senior representative, Acro Biosystems
Senior representative, BioVT
Senior representative, Fujifilm Diosynth Biotechnologies
Senior representative, Icosagen
Senior representative, Isogenica
Senior representative, KBI Biopharma
Stefan Dübel , Director, Department of Biotechnology, Technische Universität Braunschweig
Theo Rispens , Group Leader, Sanquin
Thomas Huber , Senior Investigator II, Technology Leader, Multispecific Modalities, Novartis Instituted for BioMedical Research
Ulrich Brinkmann
, Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Centre Munich
William D’all Acqua
, Vice President of R&D, MedImmune
Zhaoyang (Megan) Li
, Director Clinical Pharmacology, Sanofi


World Immunotherapy Congress

Ahuva Nissim , Reader in Antibody and Therapeutic Engineering Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University
Alain Vertes , Managing Director, NxR Biotechnologies
Daniela Cipolletta
, Lab Head, Investigator III, Immuno-Oncology, Novartis
Dario Neri
, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich
Eric Halioua
, President and Chief Executive Officer, PDC*line Pharma
Frédéric Triebel
, Chief Scientific Officer, Chief Medical Officer, Prima BioMed
Hans-Peter Gerber
, CSO, Maverick Therapeutics
Joern Schmitz
, Head, Department of Immunotherapy, Fraunhofer IME
Jose Saro
, Senior Translational Medicine Leader, Roche
M. Anthony Moody
, Associate Professor, Department of Paediatrics, Division of Infectious Diseases, Duke University Medical Centre
Martin Welschof
, Chief Executive Officer, Opsona Therapeutics
Martina Canestraro
, Senior Research Scientist, Immunocore
Roy Baynes
, SVP and Head Global Clinical Development, Chief Medical Officer, Merck, Sharp & Dohme (MSD)
Shane Olwill
, Head of Immuno-Oncology, Pieris Pharmaceuticals 
Sidath Katagampola
, Biomarker Development Sciensist, Centre for Drug Development, Cancer Research UK


Clinical Trials

Stephen Nabarro , Head Clinical ops and data, Cancer Research UK
Jonathan Sheffield
Jim Kremidas,
 Director,  Association of Clinical Research Professionals 
Andy Lee
, Head of Global Clinical Trial Operations, Novartis 
Eileen Dergarabetian
, Head of Medical Information and engagement, Novartis
Joana Claverol
, Clinical Research Unit Manager, Sant Joan de Deu Barcelona Children's Hospital, Research Foundation
Suvodip Shaw
, Global Central Monitoring Operations Manager, Novartis


HPAPI World Congress

Wendel Doubleday , Sr Director, Process Research and Development, Seattle Genetics 
Karoline Betchtold Peters
, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis
Justin Mason Home,
Director, HPAPI Project Services Ltd
Martin Axon
, Principle Occupational Hygienist, SafeBridge  
Marc Abromovitz
, Director, Occupational Health and Hygiene, Novartis  
Ildiko Ziegler
, Distinguished Validation Expert, Gedeon Richter
Reinhold Maeck
, Associate Director Tech-Transfers, Boehringer Ingelheim
Andreas Schreiner
, Director of Validation, Manufacturing Science and Technology, Novartis 
González Borroto
, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.Toral 
Toral Mehta
, Head of Industrial Hygiene and Containment, Sandoz 
Jack Brown
, Sr Principle Scientist, Boehringer Ingelheim
Juergen Knoebel
, Senior Advisor - Global Technical Operations Quality Systems/Quality Management, Roche
Alessandro Brigo
, Principal Scientist, Roche




2017 Speakers


Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc

Tudor Arvinte at World Biosimilar Congress

Philip Ball, Market Access Manager, Napp Pharmaceuticals

Philip Ball at World Biosimilar Congress

Fereshteh Barei, Health Economist, LEGOS Paris Dauphine University

Fereshteh Barei at World Biosimilar Congress

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Dr Alain Beck at World Biosimilar Congress

Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe Gmbh

Caroline Boulliat at World Biosimilar Congress

Joanna Brougher, Owner & Principal, BioPharma Law Group, PLLC, Biotech, Pharma and Medical Device IP and Corporate Co, BioPharma Law Group PLLC

Joanna Brougher at World Biosimilar Congress

Divya Chadha Manek, Head of Business Development (Commercial), National Institute for Health Research (NIHR)

Divya Chadha Manek at World Biosimilar Congress

Dan Cimpoeru, Board Member, European Cancer Patient Coalition

Dan Cimpoeru at World Biosimilar Congress

Anne Cook, Biologicals Quality Assessor, M.H.R.A.

Anne Cook at World Biosimilar Congress

Margaret Dolan, Regional Pharmacy Procurement Specialist, N.H.S.

Margaret Dolan at World Biosimilar Congress

Pieter Dylst, Senior Manager Market Access, Medicines for Europe

Pieter Dylst at World Biosimilar Congress

Catherine Evans, Business Development Manager for Biopharma, Bruker U.K. Ltd

Catherine Evans at World Biosimilar Congress

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

Mathias Flume at World Biosimilar Congress

Francois Xavier Frapaise MD, CMO, Merck Biosimilars

Francois Xavier Frapaise MD at World Biosimilar Congress

Uwe Gudat, Head of Safety, Biosimilars, Merck & Cie

Uwe Gudat at World Biosimilar Congress

Jatinder Harchowal, Jatinder Harchowal Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Royal Marsden NHS Foundation Trust

Jatinder Harchowal at World Biosimilar Congress

Ian Henshaw, Head of Business Operations, Biogen

Ian Henshaw at World Biosimilar Congress

Forrest Hu, General Manager of International Business, 3SBio Inc

Forrest Hu at World Biosimilar Congress

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Ruediger Jankowsky at World Biosimilar Congress

Peter Jorgensen, Chief Executive Officer, I.G.L.

Peter Jorgensen at World Biosimilar Congress

Parminder Kaur, CEO, RegPak BioPharma Consulting

Parminder Kaur at World Biosimilar Congress

Tarek Kilani, Former Head of Pharmacy & Continuing Medical Education Coordinator, Emirates French Hospital Llc

Tarek Kilani at World Biosimilar Congress

Martin Knight, Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine, Covance

Martin Knight at World Biosimilar Congress

Jenny Koppelkamm, Market Access Director, Takeda

Jenny Koppelkamm at World Biosimilar Congress

William Christopher Lamanna, Laboratory Head of Protein Characterization, Sandoz Inc

William Christopher Lamanna at World Biosimilar Congress

Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen

Adam Levysohn at World Biosimilar Congress

Patrick Liu, Vice President of Global Biologics R&D and Head of Biologics, Assays and Technology, Teva Pharmaceuticals U.S.A.

Patrick Liu at World Biosimilar Congress

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at World Biosimilar Congress

Márcia Martini Bueno, Institucional Affairs Director, Libbs Pharmaceutica Ltda

Márcia Martini Bueno at World Biosimilar Congress

Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan

Victor Lino Mendonça at World Biosimilar Congress

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Gopalan Narayanan at World Biosimilar Congress

Cecil Nick, Vice President, PAREXEL

Cecil Nick at World Biosimilar Congress

Ber Oomen, Executive Secretary and Treasurer, ‎European Specialist Nurses Organisations

Ber Oomen at World Biosimilar Congress

Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG

Mareike Ostertag at World Biosimilar Congress

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines

Michael Reilly at World Biosimilar Congress

Joaquin Rodrigo, Founder President, BIOSIM Spanish Association of Biosimilars

Joaquin Rodrigo at World Biosimilar Congress

Dr Stacie Ropka, Partner, Axinn

Dr Stacie Ropka at World Biosimilar Congress

Karsten Roth, Director Clinical Operations, Cinfa Biotech

Karsten Roth at World Biosimilar Congress

Ingrid Schwarzenberger, Head of Global Regulatory Affairs Biopharmaceuticals, Sandoz Biopharmaceuticals Gmbh

Ingrid Schwarzenberger at World Biosimilar Congress

Anjan Selz, Vice President – Head of Biosimilars EMEA, Lupin Europe Ltd

Anjan Selz at World Biosimilar Congress

Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc

Tim Shea at World Biosimilar Congress

Shantreddy Soogareddy, Associate Director - External Development R&D (Alliance and Project management), Dr. Reddy's Laboratories Limited

Shantreddy Soogareddy at World Biosimilar Congress

George Stefanov, Marketing Operations Director Biologics, Europe, Mylan

George Stefanov at World Biosimilar Congress

Don Stewart, President and Chief Executive Officer, PlantForm Corporation

Don Stewart at World Biosimilar Congress

Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina

Gianluca Trifirò at World Biosimilar Congress

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Florian Turk at World Biosimilar Congress

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill at World Biosimilar Congress

Manfred Weiler, Senior Vice President, Medical & Scientific Strategy, INC Research

Manfred Weiler at World Biosimilar Congress

Robert Wojciechowski, Vice President, Global Regulatory Consulting, INC Research/inVentiv Health

Robert Wojciechowski at World Biosimilar Congress

Elena Wolff-Holz, Elena Wolff-Holz, Chair, Biosimilar Medicinal Products Working Party (BMWP), Paul Ehrlich Institut

Elena Wolff-Holz at World Biosimilar Congress

René Wuttke, Bioanalytical Principal Investigator, Global Bioanalytical Services, Celerion Inc.

René Wuttke at World Biosimilar Congress


Mark Your Calendars Now!
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates